Document Type
Patent
Publication Date
December 2010
Patent Number
7846900
Abstract
The present invention includes a method of utilizing four peptide hormones to inhibit the growth of cancer(s). A dramatic decrease in the number of human pancreatic adenocarcinoma cells (i.e., the type of cancer with the highest mortality, with patients only surviving four months) was observed responsive to treatment. The application of the invention would be to utilize one or more of these peptide hormones alone and/or in combination to treat cancer. The ability of these peptide hormones to decrease the number of adenocarcinoma cells has implications for adenocarcinomas at other sites in the body with the majority of cancers of the breast, colon and prostate also being adenocarcinomas. Adenocarcinomas also occur in the lung and other tissues. Treatment of a wide variety of cancers in addition to adenocarcinomas is anticipated by the present invention.
Application Number
12/346,192
Recommended Citation
Vesely, David L., "Cancer treatment using C-type natriuretic peptide" (2010). USF Patents. 539.
https://digitalcommons.usf.edu/usf_patents/539
Assignees
University of South Florida
Filing Date
12/30/2008
Primary/U.S. Class
514/12
